K. A. Ruchina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
K. A. Ruchina has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Nina A. Gorban
A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
2 shared publications - A. G. Kudaybergenova
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia
1 shared publication - I. E. Ingel
A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
1 shared publication - V. A. Biryukov
A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
1 shared publication
Latest Publications
- 14 October 2026
- Published by "MedINK" Publishing House in Oncopathology
- Vol. 9 (3)
Morphological changes after radiation therapy for prostate cancer
This review summarizes data from recent decades on morphological changes in prostate tissue following radiation therapy, including external beam radiation and brachytherapy. Structural, cytological and immunohistochemical changes in both normal tissue and adenocarcinoma are discussed, along with diagnostic pitfalls in the assessment of residual tumor and the interpretation of Gleason score after irradiation. Particular attention is given to the prognostic value of post-treatment biopsy, definition of biochemical recurrence, and prostate-specific antigen bounce phenomenon after brachytherapy.
- 14 October 2026
- Published by "MedINK" Publishing House in Oncopathology
- Vol. 9 (3)
Morphological changes after radiation therapy for prostate cancer
This review summarizes data from recent decades on morphological changes in prostate tissue following radiation therapy, including external beam radiation and brachytherapy. Structural, cytological and immunohistochemical changes in both normal tissue and adenocarcinoma are discussed, along with diagnostic pitfalls in the assessment of residual tumor and the interpretation of Gleason score after irradiation. Particular attention is given to the prognostic value of post-treatment biopsy, definition of biochemical recurrence, and prostate-specific antigen bounce phenomenon after brachytherapy.
- Open Access
- 19 February 2026
- Published by Publishing House ABV Press in Oncopathology
- Vol. 8 (4)
Histological grading of renal cell carcinoma biopsies
Background. Transcutaneous biopsy is the key technique of preoperative diagnosis of kidney tumors including determination of histological grade (G). Accuracy of biopsy specimen grading remains a topic of discussion. Aim. To compare nuclear grading of clear cell and papillary renal cell carcinomas (RCC) in biopsy and surgical specimens, determine the causes of discrepancies. Materials and methods. Retrospective study of 39 cases of clear cell and papillary RCC (34 and 5, respectively) was conducted. Evaluated characteristics included G grade per the World Health Organization / International Society of Urological Pathology (ISUP) system, tumor heterogeneity, presence of necrosis, quantitative parameters of biopsy specimens (column length, tumor extent, diagnostically relevant tumor extent), tumor size, and рТ stage. Results. Grading in the results of biopsy and surgical specimen studies were the same in 41 % of cases. Systemic tendency to downgrading in biopsy was observed: 77 % of biopsy specimens were diagnosed as G1–G2 while in the surgical specimens the percentage of G3–G4 was 50 %. Discrepancies are associated with tumor heterogeneity (82.6 % in the discrepancy group versus 31.2 % in the agreement group), bigger tumor size (7.0 cm in the discrepancy group versus 4.6 cm in the agreement group), and low diagnostically significant tumor extent in the biopsy specimen (55 % in the discrepancy group versus 71 % in the agreement group). Reliability of diagnosis varied depending on initial biopsy grading: G4 grade was characterized by 100 % agreement while G1 only by 9 %. Conclusion. RCC biopsy grading has limited accuracy due to downgrading. Reliability of the result depends on two key factors: quality of biopsy material (sufficient volume and diagnostically significant tumor extent) and tumor characteristics (size, heterogeneity, stage). Pathology report on biopsy must include not only the grade but a commentary on the quality of the specimen and potential limitations of interpretation.
- 19 February 2026
- Published by Publishing House ABV Press in Oncopathology
- Vol. 8 (4)
Open AccessHistological grading of renal cell carcinoma biopsies
Background. Transcutaneous biopsy is the key technique of preoperative diagnosis of kidney tumors including determination of histological grade (G). Accuracy of biopsy specimen grading remains a topic of discussion. Aim. To compare nuclear grading of clear cell and papillary renal cell carcinomas (RCC) in biopsy and surgical specimens, determine the causes of discrepancies. Materials and methods. Retrospective study of 39 cases of clear cell and papillary RCC (34 and 5, respectively) was conducted. Evaluated characteristics included G grade per the World Health Organization / International Society of Urological Pathology (ISUP) system, tumor heterogeneity, presence of necrosis, quantitative parameters of biopsy specimens (column length, tumor extent, diagnostically relevant tumor extent), tumor size, and рТ stage. Results. Grading in the results of biopsy and surgical specimen studies were the same in 41 % of cases. Systemic tendency to downgrading in biopsy was observed: 77 % of biopsy specimens were diagnosed as G1–G2 while in the surgical specimens the percentage of G3–G4 was 50 %. Discrepancies are associated with tumor heterogeneity (82.6 % in the discrepancy group versus 31.2 % in the agreement group), bigger tumor size (7.0 cm in the discrepancy group versus 4.6 cm in the agreement group), and low diagnostically significant tumor extent in the biopsy specimen (55 % in the discrepancy group versus 71 % in the agreement group). Reliability of diagnosis varied depending on initial biopsy grading: G4 grade was characterized by 100 % agreement while G1 only by 9 %. Conclusion. RCC biopsy grading has limited accuracy due to downgrading. Reliability of the result depends on two key factors: quality of biopsy material (sufficient volume and diagnostically significant tumor extent) and tumor characteristics (size, heterogeneity, stage). Pathology report on biopsy must include not only the grade but a commentary on the quality of the specimen and potential limitations of interpretation.